BioCryst Provides Corporate Update and Reports Second Quarter 2012 Financial Results
06:30 EDT 2 Aug 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
BioCryst
Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced financial
results for the second quarter and six months ended June 30, 2012.
“Following the completion of the preclinical safety studies of both BCX5191
...
Other Sources for this Article
BioCryst Pharmaceuticals
Investors:
Robert Bennett,
+1-919-859-7910
or
WCG
Media:
Catherine Kyroulis,
+1-212-301-7174
More From BioPortfolio on "BioCryst Provides Corporate Update and Reports Second Quarter 2012 Financial Results"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
